REG - Kromek Group PLC - Kromek enters agreement with Smiths Detection Inc.

KromekAnnouncement

07/07/2022 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220707:nRSG6042Ra&default-theme=true

RNS Number : 6042R  Kromek Group PLC  07 July 2022

7 July 2022

 

Kromek Group plc

("Kromek" or the "Group")

 

Kromek enters agreement with Smiths Detection Inc.

Agreement to deliver radiation detection equipment to North & South
America

 

Kromek Group plc, a leading developer of radiation and bio-detection
technology solutions for the advanced imaging and CBRN detection segments,
announces that it has entered into a distribution agreement with Smiths
Detection Inc. ("Smiths"), a global leader in threat detection and security
screening technologies.

 

Under the terms of the agreement, Smiths will distribute the Group's wearable
radiation detection and identification solutions to North and South American
markets. Smiths will be focused on marketing and distributing Kromek's D3 and
D5 series of wearable radiation detectors, which are designed to enable first
responders, armed forces, border security and other CBRN experts to detect
radiological threats such as dirty bombs, radioactive contamination
and smuggling of radioactive substances.

 

Smiths Detection, part of Smiths Group, is a global leader in threat detection
and screening technologies for aviation, ports and borders, defence and urban
security markets. Its experience and history across more than 40 years at the
frontline, enables Smiths Detection to deliver the solutions needed to protect
society from the threat and illegal passage of explosives, prohibited weapons,
contraband, toxic chemicals and narcotics.

 

Dr Arnab Basu, Chief Executive Officer of Kromek, said:

 

"We are delighted to partner with Smiths Detection, which has been at the
forefront of providing solutions needed to protect society for over four
decades. Our wearable D3 and D5 family of products are closely aligned to the
needs of Smiths Detection's customer base and complement their existing
product offering. We look forward to working with Smiths Detection to deliver
our solutions to customers across North and South America."

 

 

For further information, please contact:

 

 Kromek Group plc
 Arnab Basu, CEO                                                 +44 (0)1740 626 060

 Paul Farquhar, CFO

 finnCap Ltd (Nominated Adviser and Broker)
 Geoff Nash/Kate Bannatyne/George Dollemore - Corporate Finance  +44 (0)20 7220 0500
 Tim Redfern/Charlotte Sutcliffe - ECM

 Luther Pendragon (Financial PR)
 Harry Chathli/Claire Norbury                                    +44 (0)20 7618 9100

 

 

About Kromek Group plc

Kromek Group plc is a leading developer of radiation detection and
bio-detection technology solutions for the advanced imaging and CBRN detection
segments. Headquartered in County Durham, UK, Kromek has manufacturing
operations in the UK and US, delivering on the vision of enhancing the quality
of life through innovative detection technology solutions.

 

The advanced imaging segment comprises the medical (including CT and SPECT),
security and industrial markets. Kromek provides its OEM customers with
detector components, based on its core cadmium zinc telluride (CZT) platform,
to enable better detection of diseases such as cancer and Alzheimer's,
contamination in industrial manufacture and explosives in aviation
settings.

 

In CBRN detection, the Group provides nuclear radiation detection solutions to
the global homeland defence and security market. Kromek's compact, handheld,
high-performance radiation detectors, based on advanced scintillation
technology, are primarily used to protect critical infrastructure and urban
environments from the threat of 'dirty bombs'.

 

The Group is also developing bio-security solutions in the CBRN detection
segment. These consist of fully automated and autonomous systems to detect a
wide range of airborne pathogens.

 

Kromek is listed on AIM, a market of the London Stock Exchange, under the
trading symbol 'KMK'.

 

Further information is available at www.kromek.com (http://www.kromek.com) .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRDBGDRRBGDGDL